3.78
+0.03(+0.80%)
Currency In USD
| Previous Close | 3.75 |
| Open | 3.74 |
| Day High | 3.82 |
| Day Low | 3.6 |
| 52-Week High | 4.5 |
| 52-Week Low | 0.76 |
| Volume | 66,917 |
| Average Volume | 117,613 |
| Market Cap | 155.09M |
| PE | -10.5 |
| EPS | -0.36 |
| Moving Average 50 Days | 3.83 |
| Moving Average 200 Days | 2.71 |
| Change | 0.03 |
If you invested $1000 in Apyx Medical Corporation (APYX) since IPO date, it would be worth $584.23 as of February 21, 2026 at a share price of $3.78. Whereas If you bought $1000 worth of Apyx Medical Corporation (APYX) shares 5 years ago, it would be worth $369.14 as of February 21, 2026 at a share price of $3.78.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference
GlobeNewswire Inc.
Feb 18, 2026 1:00 PM GMT
CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announ
Apyx Medical Corporation to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
GlobeNewswire Inc.
Jan 29, 2026 1:00 PM GMT
CLEARWATER, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announ
Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results
GlobeNewswire Inc.
Jan 12, 2026 1:00 PM GMT
Surgical Aesthetics revenue increased approximately 38% year-over-year in the fourth quarter of 2025, including an increase of approximately 51% in the U.S. following the launch of AYONCLEARWATER, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Apyx Medica